Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Stoll

Showing results (21-30 of 222) with videos related to

Pageof 23
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1991
Overprolonged adjuvant tamoxifen therapy in breast cancerB A Stoll
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Spontaneous regression of cancer: new insightsB A Stoll
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implicationsB A Stoll
British Medical Journal|May 20, 1978
Contraceptive steroids and breast cancerB A Stoll
British Journal of Cancer|May 1, 1994
Breast cancer: the obesity connectionB A Stoll
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1991
Quantifying the risk of breast cancerB A Stoll
Lancet (London, England)|March 12, 1988
Balancing cost and benefit in treatment of late cancerB A Stoll
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1993
Can unorthodox cancer therapy improve quality-of-life?B A Stoll
Lancet (London, England)|June 17, 1972
In-vitro oestrogen sensitivity of breast cancerB A Stoll
Scottish Medical Journal|January 1, 1979
Medical treatment of breast cancerB A Stoll
Pageof 23

Showing results (21-30 of 222) with videos related to

Sort By:
Pageof 23
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1991
Overprolonged adjuvant tamoxifen therapy in breast cancerB A Stoll
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Spontaneous regression of cancer: new insightsB A Stoll
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implicationsB A Stoll
British Medical Journal|May 20, 1978
Contraceptive steroids and breast cancerB A Stoll
British Journal of Cancer|May 1, 1994
Breast cancer: the obesity connectionB A Stoll
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1991
Quantifying the risk of breast cancerB A Stoll
Lancet (London, England)|March 12, 1988
Balancing cost and benefit in treatment of late cancerB A Stoll
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1993
Can unorthodox cancer therapy improve quality-of-life?B A Stoll
Lancet (London, England)|June 17, 1972
In-vitro oestrogen sensitivity of breast cancerB A Stoll
Scottish Medical Journal|January 1, 1979
Medical treatment of breast cancerB A Stoll
Pageof 23